ANNOVIS BIO INC. COMMON STOCK

Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients

18 Dec 2025 16:35:00 By Nasdaq GlobeNewswire

Annovis to Host Corporate Update Webinar on January 28, 2026

16 Dec 2025 08:00:00 By Nasdaq GlobeNewswire

Annovis To Present at the 2025 Annual Meeting of the Parkinson Study Group

03 Dec 2025 08:00:00 By Nasdaq GlobeNewswire

Annovis Announces Two Presentations at the CTAD 2025 Conference

24 Nov 2025 08:00:00 By Nasdaq GlobeNewswire

Annovis Announces FDA Meeting to Discuss Parkinson's Disease Dementia Program; Reaffirms FDA Alignment on Pivotal Phase 3 Alzheimer's Disease Study

18 Nov 2025 08:00:02 By Nasdaq GlobeNewswire

Annovis Reports New Biomarker Data Linking Amyloid Co-Pathology to Accelerated Cognitive Decline in Parkinson's Patients

17 Nov 2025 08:00:00 By Nasdaq GlobeNewswire

Annovis Provides Corporate Updates and Reports Third Quarter 2025 Financial Results

12 Nov 2025 08:00:01 By Nasdaq GlobeNewswire

Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer’s Program

06 Nov 2025 08:00:00 By Nasdaq GlobeNewswire

Annovis Announces $3.4 Million Registered Direct Offering of Common Stock Priced At-the-Market under the NYSE Rules

27 Oct 2025 08:00:00 By Nasdaq GlobeNewswire

Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock

15 Oct 2025 17:15:00 By Nasdaq GlobeNewswire

Annovis Announces $6 Million Registered Direct Offering of Common Stock

10 Oct 2025 08:31:38 By Nasdaq GlobeNewswire

Annovis Announces Novel Biomarker Data in Alzheimer’s Patients Supporting Buntanetap’s Potential as a Disease-Modifying Treatment

09 Oct 2025 07:30:00 By Nasdaq GlobeNewswire

Annovis Appoints Mark Guerin as Chief Financial Officer

25 Sep 2025 07:30:00 By Nasdaq GlobeNewswire

Annovis Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap

16 Sep 2025 07:30:00 By Nasdaq GlobeNewswire

Annovis to Present at the H.C. Wainwright 27th Annual Global Investment Conference

02 Sep 2025 08:00:00 By Nasdaq GlobeNewswire

Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results

12 Aug 2025 16:05:01 By Nasdaq GlobeNewswire

Annovis Completes Full Patent Transfer to Crystal Buntanetap

07 Aug 2025 08:00:01 By Nasdaq GlobeNewswire

Annovis to Attend the AAIC 2025 with Four Poster Presentations

26 Jun 2025 08:00:00 By Nasdaq GlobeNewswire

Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance

19 Jun 2025 06:30:00 By Nasdaq GlobeNewswire

Annovis to Host Webinar and Live Q&A on June 24, 2025

05 Jun 2025 08:00:00 By Nasdaq GlobeNewswire